Skip to content
Search

Latest Stories

Impact of temporary pharmacy closures on patients: PDA submits evidence to PAC inquiry

Impact of temporary pharmacy closures on patients: PDA submits evidence to PAC inquiry

Escalating pharmacy closures forcing patients, who are being treated for addiction to illegal substances, to turn to the illegal market, warns PDA. 

The Pharmacists' Defence Association (PDA) recently provided written evidence to the Public Accounts Committee (PAC) inquiry on reducing the harm from illegal drugs, specifically highlighting the impact of temporary pharmacy closures on patients.


As defined by the association, a temporary closure is “where the pharmacy business, despite being contracted to the NHS to be open and to provide services to the public decides instead to close the pharmacy for partial days or one or more consecutive full days.”

This creates a barrier for patients to access treatment supporting their recovery from the use of illegal drugs, it said.

The PDA drew the Committee’s attention to the failure of the health departments to address the issue of temporary pharmacy closures, which has escalated significantly in the recent past.

As evidence, the PDA provided the Committee with published information along with data obtained by the association from Freedom of Information requests that showed the wide scale and GB-wide nature of temporary pharmacy closures.

Responding to the inquiry, the PDA also outlined the role of pharmacists in helping patients being treated for addiction to illegal substances, including the supply of controlled drugs such as methadone.

“The supply of methadone from pharmacies, which is personally supervised by a pharmacist, ensures that these vulnerable patients have access to safe and legal medicines as a substitute to illegally obtained opioids,” the PDA said.

The association added that even the smallest disruption in accessing the treatment can force vulnerable patients to turn to the illegal market with all the consequential risks.

Hence, it concluded that the issue of temporary pharmacy closures and the wider issue of permanent pharmacy closures “must be considered” when patients are being supported to withdraw from buying drugs on the illegal market.

The PAC accepted and published 22 written submissions in their call for evidence on these issues, including the evidence submitted by the PDA.

More For You

NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Pharmacy First: Government confirms £215 million boost to realise its full potential

From April 2025, the consultation fee for Pharmacy First Minor Illness and Clinical Pathways will rise from £15 to £17.

‘Pharmacy First hasn't realised its full potential,’ says Stephen Kinnock

Health Minister Stephen Kinnock has acknowledged that Pharmacy First has huge potential, noting that the service “hasn't realised its full potential.”

As part of efforts to enhance the service, Kinnock yesterday (30) announced £215 million in additional funding for Pharmacy First and other Primary Care Access Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less